Current Medical Science
Huazhong University of Science and Technology
DOI 10.1007/s11596-021-2317-2 , Volume: 41 , Issue: 1 , Pages: 51-57
Article Type: review-article, Article History

Table of Contents

Highlights

Notes

Abstract

Coronavirus disease 2019 (COVID-19) occurs in the influenza season and has become a global pandemic. The present study aimed to examine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with influenza A virus (IAV) in an attempt to provide clues for the antiviral interventions of co-infected patients. We described two patients who were co-infected with SARS-CoV-2 and IAV treated at Wuhan Union Hospital, China. In addition, we performed a review in PubMed, Web of Science and CNKI (from January 1 up to November 1, 2020) with combinations of the following key words: “COVID-19, SARS-COV-2, influenza A and co-infection”. A total of 28 co-infected patients were enrolled in the analysis. Of the 28 patients, the median age was 54.5 years (IQR, 34.25–67.5) and 14 cases (50.0%) were classified as severe types. The most common symptoms were fever (85.71%), cough (82.14%) and dyspnea (60.71%). Sixteen patients had lymphocytopenia on admission and 23 patients exhibited abnormal radiological changes. The median time from symptom onset to hospital admission was 4 days (IQR, 3–6), and the median time of hospital stay was 14 days (IQR, 8.5–16.75). In conclusion, patients with SARS-COV-2 and IAV co-infection were similar to those infected with SARS-COV-2 alone in symptoms and radiological images. SARS-COV-2 co-infection with IAV could lead to more severe clinical condition but did not experience longer hospital stay compared with patients infected with SARS-COV-2 alone.

Keywords
Xiang, Wang, Ye, He, Wei, Ma, Li, Chen, Wang, and Zhou: Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review

Notes

This work was supported by the National Natural Science Foundation of China (No. 81973990, No. 81900096, and No.81770090) and Fundamental Research Funds for the Central Universities (No. 2020kfyXGYJ030).
Conflict of Interest Statement:

The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.

References

    Lu R, Zhao X, Li J, . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. 395: 10224 565-574 doi: 10.1016/S0140-6736(20)30251-8

    Wang D, Hu B, Hu C, . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020. 323: 11 1061 doi: 10.1001/jama.2020.1585

    Huang C, Wang Y, Li X, . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020. 395: 10223 497-506 doi: 10.1016/S0140-6736(20)30183-5

Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology, 2020:200230

    Zhang R, Ouyang H, Fu L, . CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol 2020. 30: 8 4417-4426 doi: 10.1007/s00330-020-06854-1

    Thompson WW. Influenza-Associated Hospitalizations in the United States. JAMA 2004. 292: 11 1333 doi: 10.1001/jama.292.11.1333

    Lafond KE, Narr H, Rasooly MH, . Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis. Plos Med 2016. 13: 3 e1001977 doi: 10.1371/journal.pmed.1001977

    Collins JP, Campbell AP, Openo K, . Clinical Features and Outcomes of Immunocompromised Children Hospitalized with Laboratory-Confirmed Influenza in the United States, 2011–2015. J Pediat Inf Dis Soc 2019. 8: 6 539-549 doi: 10.1093/jpids/piy101

    Ercen DO, Arslan S, Akdogan O, . Clinical, radiological and prognostic features of influenza cases in the influenza epidemic during years 2016–2017. Tuberk Toraks 2018. 66: 2 144-199

10 

    McCullers JA. Insights into the Interaction between Influenza Virus and Pneumococcus. Clin Microbiol Rev 2006. 19: 3 571-582 doi: 10.1128/CMR.00058-05

11 

    Martin-Loeches I, J , Schultz M, Vincent J, . Increased incidence of co-infection in critically ill patients with influenza. Intens Care Med 2017. 43: 1 48-58 doi: 10.1007/s00134-016-4578-y

12 

    Ding Q, Lu P, Fan Y, . The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020. 92: 9 1549-1555 doi: 10.1002/jmv.25781

13 

    Wu X, Cai Y, Huang X, . Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis 2020. 26: 6 1324-1326 doi: 10.3201/eid2606.200299

14 

    Khodamoradi Z, Moghadami M, Lotfi M. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. Arch Iran Med 2020. 23: 4 239-243 doi: 10.34172/aim.2020.04

15 

National Health Commission, State Administration of Traditional Chinese Medicine. Diagnosis and Treatment of Protocol of COVID-19. http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989.Shtml, 2020-03-03

16 

17 

    Sha GJ. Co-infection of SARS CoV-2 and influenza A in a child: a case report. Henan J Prev Med (Chinese) 2020. 31: 05 323-324

18 

    Konala VM, Adapa S, Naramala S, . A Case Series of Patients Coinfected With Influenza and COVID-19. J Investig Med High Impact Case Rep 2020. 8: 1562230171

19 

    D’Abramo A, Lepore L, Palazzolo C, . Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Minireview of the literature. Int J Infect Dis 2020. 97: 236-239 doi: 10.1016/j.ijid.2020.06.056

20 

    Pongpirul WA, Mott JA, Woodring JV, . Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand. Emerg Infect Dis 2020. 26: 7 1580-1585 doi: 10.3201/eid2607.200598

21 

    Wehl G, Laible M, Rauchenzauner M. Co-infection of SARS CoV-2 and influenza A in a Pediatric Patient in Germany. Klin Padiatr 2020. 232: 4 217 doi: 10.1055/a-1163-7385

22 

    Zheng X, Wang H, Su Z, . Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China. J Infect 2020. 81: 2 e128-e129 doi: 10.1016/j.jinf.2020.05.041

23 

    Hashemi SA, Safamanesh S, Ghafouri M, . Co-infection with COVID-19 andinfluenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J Med Virol 2020. 92: 11 2319-2321 doi: 10.1002/jmv.26014

24 

    Konala VM, Adapa S, Gayam V, . Co-infection with Influenza A and COVID-19. European J Case Rep Intern Med 2020. 7: 5 1 doi: 10.12890/2020_001656

25 

    Azekawa S, Namkoong H, Mitamura K, . Co-infection with SARS-CoV-2 and influenza A virus. IDCases 2020. 20: e775 doi: 10.1016/j.idcr.2020.e00775

26 

    Singh B, Kaur P, Reid R, . COVID-19 and Influenza Co-Infection: Report of Three Cases. Cureus 2020. 12: 8 e9852

27 

    Ozaras R, Cirpin R, Duran A, . Influenza and COVID-19 coinfection: Report of six cases and review of the literature. J Med Virol 2020. 92: 11 2657-2665 doi: 10.1002/jmv.26125

28 

    Cuadrado-Payán E, Montagud-Marrahi E, Torres-Elorza M, . SARS-CoV-2 and influenza virus co-infection. Lancet 2020. 395: 10236 e84 doi: 10.1016/S0140-6736(20)31052-7

29 

    Kakuya F, Okubo H, Fujiyasu H, . The First Pediatric Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Risk of Co-Infection with Other Respiratory Viruses. Jpn J Infect Dis 2020. 73: 5 377-380 doi: 10.7883/yoken.JJID.2020.181

30 

    Goka E, Vallely P, Mutton K, . Influenza A viruses dual and multiple infections with other respiratory viruses and risk of hospitalisation and mortality. Influenza Other Resp 2013. 7: 6 1079-1087 doi: 10.1111/irv.12020

31 

    Meskill SD, Revell PA, Chandramohan L, . Prevalence of co-infection between respiratory syncytial virus and influenza in children. Am J Emerg Med 2017. 35: 3 495-498 doi: 10.1016/j.ajem.2016.12.001

32 

    Guan W, Ni Z, Hu Y, . Clinical Characteristics of Coronavirus Disease 2019 in China. New Engl J Med 2020. 382: 18 1708-1720 doi: 10.1056/NEJMoa2002032

33 

    Hashemi SA, Safamanesh S, Ghasemzadeh-Moghaddam H, . High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran. J Med Virol 2020. 93: 1008-1012 doi: 10.1002/jmv.26364

34 

    Xu K, Chen Y, Yuan J, . Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis 2020. 71: 15 799-806 doi: 10.1093/cid/ciaa351

35 

    Dobson J, Whitley RJ, Pocock S, . Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015. 385: 9979 1729-1737 doi: 10.1016/S0140-6736(14)62449-1

36 

    Pinky L, Dobrovolny HM. SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?. J Med Virol 2020. 92: 11 2623-2630 doi: 10.1002/jmv.26098

37 

European Centre For Disease Control. Scientific-advice-neuraminidase-inhibitors-2017. https://www.ecdc.europa.eu/sites/default/files/documents/Scientific-advice-neuraminidase-inhibitors-2017.

38 

Centers for Disease Control and Prevention. Influenza, https://www.cdc.gov/flu/treatment/whatyoushould.htm

39 

    McCullers JA, Bartmess KC. Role of Neuraminidase in Lethal Synergism between Influenza Virus and Streptococcus pneumoniae. J Infect Dis 2003. 187: 6 1000-1009 doi: 10.1086/368163

40 

    Arabi YM, Mandourah Y, Al-Hameed F, . Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Resp Crit Care 2018. 197: 6 757-767 doi: 10.1164/rccm.201706-1172OC

41 

    Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. Plos Med 2006. 3: 9 e343 doi: 10.1371/journal.pmed.0030343

42 

    Nowak MD, Sordillo EM, Gitman MR, . Coinfection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?. J Med Virol 2020. 92: 10 1699-1700 doi: 10.1002/jmv.25953

43 

    Kim D, Quinn J, Pinsky B, . Rates of Co-infection between SARS-CoV-2 and Other Respiratory Pathogens. JAMA 2020. 323: 20 2085-2086 doi: 10.1001/jama.2020.6266

44 

    Schultz-Cherry S. Viral Interference: The Case of Influenza Viruses. J Infect Dis 2015. 212: 11 1690-1691 doi: 10.1093/infdis/jiv261
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

https://www.researchpad.co/tools/openurl?pubtype=article&doi=10.1007/s11596-021-2317-2&title=Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review&author=&keyword=co-infection,COVID-19,influenza A,SARS-COV-2,&subject=Article,